Intensified Antiplatelet Treatment Reduces Major Cardiac Events in Patients with Clopidogrel Low Response: A Meta-analysis of Randomized Controlled Trials

BACKGROUND: Clopidogrel low response (CLR) is an independent risk factor of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI), and intensified antiplatelet treatments (IAT) guided by platelet function assays might overcome laboratory CLR. However, whether IAT improves...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lei, Hu, Xiao-Wei, Zhang, Shu-Hua, Li, Ji-Min, Zhu, Hui, Xu, Ke, Chen, Jun, Li, Chun-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831535/
https://www.ncbi.nlm.nih.gov/pubmed/27064045
http://dx.doi.org/10.4103/0366-6999.179786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831535/
https://www.ncbi.nlm.nih.gov/pubmed/27064045
http://dx.doi.org/10.4103/0366-6999.179786

Ejemplares similares